Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-1-21
pubmed:abstractText
Serum YKL-40 has been linked to several human cancers. We investigated the potential role of serum YKL-40 as a marker of hepatobiliary malignancies.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-10188896, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-10898311, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-10911963, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-12154041, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-12694127, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-12873813, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-12889595, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-15541818, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-15641129, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-15761078, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-15916730, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-16247463, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-16372331, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-16456816, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-17087877, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-17227236, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-17725598, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-17957792, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18003958, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18070151, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18371145, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18650368, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18802121, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-18957531, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-19075264, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-19215669, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-19765801, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-19767768, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-19793171, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-20056225, http://linkedlifedata.com/resource/pubmed/commentcorrection/21253305-20347092
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Dec
pubmed:issn
1976-2283
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
537-42
pubmed:dateRevised
2011-7-20
pubmed:year
2010
pubmed:articleTitle
Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies.
pubmed:affiliation
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.
pubmed:publicationType
Journal Article